Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.4900 (1.35%) ($13.1600 - $13.8600) on Mon. Aug. 12, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.3% (three month average) | RSI | 39 | Latest Price | $13.4900(1.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -6.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -1.65% in a week (0% probabilities). VIXM(-35%) VXX(-34%) TLT(-12%) UNG(-7%) IFRA(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.65% (StdDev 3.3%) | Hourly BBV | 0 () | Intraday Trend | 1.7% | | | |
|
1 - 5 Day Possible Target | $-5.43(-140.25%) | Resistance Level | $14.02 | 5 Day Moving Average | $12.77(5.64%) | 10 Day Moving Average | $13.14(2.66%) | 20 Day Moving Average | $14.02(-3.78%) | To recent high | -46% | To recent low | 12.1% | Market Cap | $1.002b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |